D. Knight

T. Riley, D. Knight, S. Lim, 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.

T. Riley, D. Knight, N. Foster, 2018, International journal of antimicrobial agents.

Evolutionary and Genomic Insights into Clostridioides difficile Sequence Type 11: a Diverse Zoonotic and Antimicrobial-Resistant Lineage of Global One Health Importance

P. Tsai, K. Tateda, Stuart Johnson, 2019, mBio.

Genomic Delineation of Zoonotic Origins of Clostridium difficile

T. Riley, D. Knight, 2019, Front. Public Health.

Clostridium difficile infection: Evolution, phylogeny and molecular epidemiology.

T. Riley, D. Knight, B. Elliott, 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.

D. Paterson, S. Giglio, T. Riley, 2015, The Journal of antimicrobial chemotherapy.

Surveillance for antimicrobial resistance in Australian isolates of Clostridium difﬁcile , 2013 – 14

D. Paterson, S. Giglio, T. Riley, 2015 .

Evaluation of Reduced Susceptibility to Quaternary Ammonium Compounds and Bisbiguanides in Clinical Isolates and Laboratory-Generated Mutants of Staphylococcus aureus

A. T. Freitas, I. Morrissey, G. Orefici, 2013, Antimicrobial Agents and Chemotherapy.

A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus.

R. Fani, A. T. Freitas, I. Morrissey, 2012, International journal of antimicrobial agents.

Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.

Monica Lahra, T. Riley, R. McDougall, 2021, The Journal of antimicrobial chemotherapy.

Antimicrobial resistance in Clostridium difficile ribotype 017

P. Kiratisin, T. Riley, D. Knight, 2019, Expert review of anti-infective therapy.

A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain.

R. Leong, C. Keighley, T. Riley, 2019, Anaerobe.

Clostridium difficile ribotype 017 – characterization, evolution and epidemiology of the dominant strain in Asia

P. Kiratisin, T. Riley, D. Knight, 2019, Emerging microbes & infections.

Whole‐genome sequencing links Clostridium (Clostridioides) difficile in a single hospital to diverse environmental sources in the community

T. Riley, D. Speers, D. Knight, 2021, Journal of applied microbiology.

Esculin hydrolysis negative and TcdA‐only producing strains of Clostridium (Clostridioides) difficile from the environment in Western Australia

T. Riley, D. Knight, B. Chang, 2022, Journal of applied microbiology.

Molecular Characterization of, and Antimicrobial Resistance in, Clostridioides difficile from Thailand, 2017-2018.

P. Kiratisin, T. Riley, D. Knight, 2021, Microbial drug resistance.

Nationwide Surveillance Study of Clostridium difficile in Australian Neonatal Pigs Shows High Prevalence and Heterogeneity of PCR Ribotypes

T. Riley, D. Knight, M. M. Squire, 2014, Applied and Environmental Microbiology.

Clostridium difficile in soil conditioners, mulches and garden mixes with evidence of a clonal relationship with historical food and clinical isolates.

T. Riley, D. Knight, N. Foster, 2020, Environmental microbiology reports.

Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018

Monica Lahra, T. Riley, R. McDougall, 2020, Journal of Clinical Microbiology.

Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies

T. Riley, L. Sammels, D. Knight, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal Tract

J. Baell, T. Riley, G. Carter, 2022, ACS omega.

Clostridioides difficile infection and One Health: an equine perspective

T. Riley, D. Knight, M. Bruce, 2022, Environmental microbiology.

Can sequencing improve the diagnosis and management of Clostridioides difficile infection?

T. Riley, D. Knight, K. Imwattana, 2021, Expert review of molecular diagnostics.

In silico, in vitro and in vivo analysis of putative virulence factors identified in large clostridial toxin-negative, binary toxin producing C. difficile strains.

T. Riley, D. Lyras, D. Knight, 2019, Anaerobe.

A Phenotypically Silent vanB2 Operon Carried on a Tn1549-Like Element in Clostridium difficile

T. Riley, D. Knight, B. Howden, 2016, mSphere.

Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies

T. Riley, L. Sammels, D. Knight, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound

A. McKinley, T. Riley, K. Hammer, 2018, Scientific Reports.

Natural products show diverse mechanisms of action against Clostridium difficile

T. Riley, N. Roshan, K. Hammer, 2019, Journal of applied microbiology.

Effect of natural products on the production and activity of Clostridium difficile toxins in vitro

T. Riley, N. Roshan, K. Hammer, 2018, Scientific Reports.

Persistence of Clostridium difficile RT 237 infection in a Western Australian piggery.

T. Riley, D. Hampson, D. Knight, 2016, Anaerobe.

Diversity and Evolution in the Genome of Clostridium difficile

T. Perkins, T. Riley, D. Knight, 2015, Clinical Microbiology Reviews.

Spectrum of antibacterial activity and mode of action of a novel tris-stilbene bacteriostatic compound

A. McKinley, T. Riley, K. Hammer, 2018, Scientific Reports.

Genome Analysis of Clostridium difficile PCR Ribotype 014 Lineage in Australian Pigs and Humans Reveals a Diverse Genetic Repertoire and Signatures of Long-Range Interspecies Transmission

T. Riley, D. Knight, D. Collins, 2017, Front. Microbiol..

Global evolutionary dynamics and resistome analysis of Clostridioides difficile ribotype 017

P. Kiratisin, T. Riley, D. Knight, 2021, bioRxiv.

Major genetic discontinuity and novel toxigenic species in Clostridioides difficile taxonomy

D. Paredes-Sabja, X. Didelot, K. Dingle, 2021, eLife.

Molecular characterisation of, and antimicrobial resistance in, Clostridioides difficile from Thailand, 2017-2018

P. Kiratisin, T. Riley, D. Knight, 2020, bioRxiv.

Clostridium difficile Infection in Production Animals and Avian Species: A Review.

T. Riley, D. Hampson, D. Knight, 2016, Foodborne pathogens and disease.

Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression

I. Morrissey, C. Largiadèr, M. Oggioni, 2015, BMC Genomics.

A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile.

T. Riley, D. Knight, C. Rodríguez, 2021, Microbial genomics.

Antimicrobial resistance in Clostridioides difficile

T. Riley, D. Knight, Keeley O’Grady, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile

T. Riley, D. Knight, C. Rodríguez, 2021, bioRxiv.

Genomic basis of antimicrobial resistance in non-toxigenic Clostridium difficile in Southeast Asia.

P. Kiratisin, T. Riley, D. Knight, 2020, Anaerobe.

The impact of antimicrobial resistance on induction, transmission and treatment of Clostridium difficile infection

T. Riley, D. Knight, Stacey Hong, 2019, Microbiology Australia.

Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin.

T. Riley, D. Knight, 2016, The Journal of antimicrobial chemotherapy.

Laboratory Detection of Clostridium difficile in Piglets in Australia

T. Riley, D. Knight, M. M. Squire, 2014, Journal of Clinical Microbiology.

Prevalence of Gastrointestinal Clostridium difficile Carriage in Australian Sheep and Lambs

T. Riley, D. Knight, 2013, Applied and Environmental Microbiology.

Molecular epidemiology of Clostridium difficile isolated from piglets.

V. Neela, T. Riley, D. Knight, 2019, Veterinary microbiology.

Community-acquired Clostridium difficile infection and Australian food animals

T. Riley, D. Knight, M. M. Squire, 2015 .

Contamination of Australian newborn calf carcasses at slaughter with Clostridium difficile.

T. Riley, D. Knight, B. Elliott, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Cross-Sectional Study Reveals High Prevalence of Clostridium difficile Non-PCR Ribotype 078 Strains in Australian Veal Calves at Slaughter

T. Riley, D. Knight, Sara Thean, 2013, Applied and Environmental Microbiology.

Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027

T. Riley, D. Knight, B. Elliott, 2017, PloS one.

Two cases of Clostridium difficile infection in unrelated oncology patients attributable to a single clone of C. difficile PCR ribotype 126

D. Crook, N. Gottardo, D. Eyre, 2015 .

Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.

T. Riley, D. Knight, N. Foster, 2018, Anaerobe.

Antimicrobial susceptibility of Clostridium difficile isolated in Thailand

P. Kiratisin, T. Riley, D. Knight, 2017, Antimicrobial Resistance & Infection Control.

Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.

I. Morrissey, P. Nordmann, A. MacGowan, 2013, The Journal of antimicrobial chemotherapy.